Jane Ma
Impact in
-
- Air Quality and Health Impacts
-
- Occupational and environmental lung diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inhalation and Respiratory Drug Delivery
Papers in ⓘ
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Pleural and Pulmonary Diseases 2
-
- Advanced Nanomaterials in Catalysis 4
- Co-authors
- Vincent Castranova (8 shared papers)Mark Barger (8 shared papers)Diane Schwegler‐Berry (4 shared papers)Philip Demokritou (2 shared papers)Joel M. Cohen (2 shared papers)Robert R. Mercer (2 shared papers)Georgios Pyrgiotakis (1 shared paper)David G. Frazer (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (3 papers)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2 papers)Data in Brief (2 papers)Archives of Toxicology (1 paper)Journal of Environmental Pathology Toxicology and Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Jane Ma
15 papers receiving 539 citations
Peers
Comparison fields: 5 of 94
- Health, Toxicology and Mutagenesis 163
- Pulmonary and Respiratory Medicine 187
- Materials Chemistry 212
- Chemical Health and Safety 3
- Cancer Research 48
Countries citing papers authored by Jane Ma
This map shows the geographic impact of Jane Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Ma more than expected).
Fields of papers citing papers by Jane Ma
This network shows the impact of papers produced by Jane Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Ma. The network helps show where Jane Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 137 | |
| 2 | 2002 | 63 | |
| 3 | 2001 | 63 | |
| 4 | 2015 | 57 | |
| 5 | 1997 | 50 | |
| 6 | 2017 | 47 | |
| 7 | Cis-4-[(18)F]fluoro-L-proline PET imaging of pulmonary fibrosis in a rabbit model. | 2002 | 35 |
| 8 | 2003 | 25 | |
| 9 | 2015 | 19 | |
| 10 | 2004 | 15 | |
| 11 | 2000 | 14 | |
| 12 | 2017 | 12 | |
| 13 | 1981 | 10 | |
| 14 | 2015 | 9 | |
| 15 | 1979 | 1 | |
| 16 | 2025 | 0 |
About Jane Ma
Jane Ma is a scholar working on Pulmonary and Respiratory Medicine, Materials Chemistry, Health, Toxicology and Mutagenesis, Cancer Research and Rheumatology, having authored 16 papers that have together received 557 indexed citations. Recurring topics across this work include Advanced Nanomaterials in Catalysis (4 papers), Air Quality and Health Impacts (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Pleural and Pulmonary Diseases (2 papers), Toxic Organic Pollutants Impact (2 papers), Occupational exposure and asthma (2 papers) and Graphene and Nanomaterials Applications (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (163 citations), Pulmonary and Respiratory Medicine (187 citations), Materials Chemistry (212 citations), Chemical Health and Safety (3 citations) and Cancer Research (48 citations). Jane Ma has collaborated with scholars based in United States. Frequent co-authors include Vincent Castranova, Mark Barger, Diane Schwegler‐Berry, Philip Demokritou, Joel M. Cohen, Robert R. Mercer, Georgios Pyrgiotakis, David G. Frazer, Samuel Gass and William T. Goldsmith. Their work appears in journals such as Toxicology and Applied Pharmacology, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Data in Brief, Archives of Toxicology and Journal of Environmental Pathology Toxicology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.